Midday movers: Affirm, Amazon, and More
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- S&P 500 flat as higher bond yields counter tech optimism
- Wells Fargo raises oil price targets citing ongoing supply risks
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
Amazon.com (AMZN) Mentioned Positively at Citi, Top Pick
November 29, 2023 7:57 AM ESTCiti analyst Ronald Josey reiterated a Buy rating and $177.00 price target on Amazon.com (NASDAQ: AMZN)
The analyst comments "Following our time at AWS and after hosting our 7th Annual Citi Cloud Forum with Citis Software Analysts Tyler Radke and Fatima Boolani, we... More
Amazon.com (AMZN) Mentioned Positively at Susquehanna
November 29, 2023 7:27 AM ESTSusquehanna analyst Shyam Patil reiterated a Positive rating and $185.00 price target on Amazon.com (NASDAQ: AMZN)
The analyst comments "Unveiling Amazon Q, an AI chatbot for enterprises. One of the key product announcements at this years re:Invent conference was a generative AI tool Amazon Q, a new AI-powered assistant designed for enterprises. The product, currently... More
Shopify (SHOP) holds an 'untenable valuation' - Piper Sandler
November 28, 2023 8:31 AM ESTShopify (NYSE: SHOP) shares were cut to Underweight from Neutral at Piper Sandler on Tuesday, with analyst Clarke Jeffries lowering the price target to $56 from $58 per share.
Jeffries said in a note that the firm decided to revisit its investment thesis... More
Teva Pharma 'uniquely positioned,' Jazz Pharmaceuticals set-up balanced - UBS
November 27, 2023 11:21 AM ESTInvestment bankUBS raised Teva Pharma (NYSE: TEVA) to Buy from Neutral and downgraded Jazz Pharmaceuticals (NASDAQ: JAZZ) to Neutral from Buy in separate notes to clients on Monday.
Analyst Ashwani Verma raised the TEVA price target to $13 from $11 per share, stating the brand transition is underway and launch... More
